Suppr超能文献

相似文献

1
Cocrystal Transition Points: Role of Cocrystal Solubility, Drug Solubility, and Solubilizing Agents.
Mol Pharm. 2015 Oct 5;12(10):3535-46. doi: 10.1021/acs.molpharmaceut.5b00111. Epub 2015 Aug 28.
2
Cocrystal Solubilization in Biorelevant Media and its Prediction from Drug Solubilization.
J Pharm Sci. 2015 Dec;104(12):4153-4163. doi: 10.1002/jps.24640. Epub 2015 Sep 21.
3
Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5.
Adv Drug Deliv Rev. 2016 Jun 1;101:143-166. doi: 10.1016/j.addr.2016.04.022. Epub 2016 Apr 29.
4
Engineering cocrystal solubility, stability, and pH(max) by micellar solubilization.
J Pharm Sci. 2011 Dec;100(12):5219-34. doi: 10.1002/jps.22725. Epub 2011 Sep 9.
5
Mechanistic Basis of Cocrystal Dissolution Advantage.
J Pharm Sci. 2018 Jan;107(1):380-389. doi: 10.1016/j.xphs.2017.09.014. Epub 2017 Oct 6.
6
Mitigating Cocrystal Physical Stability Liabilities in Preclinical Formulations.
J Pharm Sci. 2017 Jan;106(1):31-38. doi: 10.1016/j.xphs.2016.07.018. Epub 2016 Sep 21.
7
Cocrystal Solubility Advantage Diagrams as a Means to Control Dissolution, Supersaturation, and Precipitation.
Mol Pharm. 2019 Sep 3;16(9):3887-3895. doi: 10.1021/acs.molpharmaceut.9b00501. Epub 2019 Jul 31.
8
A novel solubilization technique for poorly soluble drugs through the integration of nanocrystal and cocrystal technologies.
Eur J Pharm Biopharm. 2016 Oct;107:142-50. doi: 10.1016/j.ejpb.2016.07.006. Epub 2016 Jul 5.
9
The role of pH and dose/solubility ratio on cocrystal dissolution, drug supersaturation and precipitation.
Eur J Pharm Sci. 2020 Sep 1;152:105422. doi: 10.1016/j.ejps.2020.105422. Epub 2020 Jun 10.
10
Understanding the Differences Between Cocrystal and Salt Aqueous Solubilities.
J Pharm Sci. 2018 Jan;107(1):113-120. doi: 10.1016/j.xphs.2017.10.033. Epub 2017 Oct 31.

引用本文的文献

1
Discovery of Cilnidipine Cocrystals with Enhanced Dissolution by the Use of Computational Tools and Semiautomatic High-Throughput Screening.
Cryst Growth Des. 2025 Apr 29;25(10):3374-3385. doi: 10.1021/acs.cgd.5c00184. eCollection 2025 May 21.
3
Polymers Enhance Chlortetracycline Hydrochloride Solubility.
Int J Mol Sci. 2024 Oct 1;25(19):10591. doi: 10.3390/ijms251910591.
4
Combination of co-crystal and nanocrystal techniques to improve the solubility and dissolution rate of poorly soluble drugs.
Pharm Res. 2022 May;39(5):949-961. doi: 10.1007/s11095-022-03243-9. Epub 2022 May 12.
6
Pharmaceutical cocrystals: A review of preparations, physicochemical properties and applications.
Acta Pharm Sin B. 2021 Aug;11(8):2537-2564. doi: 10.1016/j.apsb.2021.03.030. Epub 2021 Mar 23.
7
Enhanced Dissolution of Naproxen by Combining Cocrystallization and Eutectic Formation.
Pharmaceutics. 2021 Apr 25;13(5):618. doi: 10.3390/pharmaceutics13050618.
8
Cocrystal Solubility Advantage Diagrams as a Means to Control Dissolution, Supersaturation, and Precipitation.
Mol Pharm. 2019 Sep 3;16(9):3887-3895. doi: 10.1021/acs.molpharmaceut.9b00501. Epub 2019 Jul 31.
10
Cocrystals Mitigate Negative Effects of High pH on Solubility and Dissolution of a Basic Drug.
Cryst Growth Des. 2018 Mar 7;18(3):1358-1366. doi: 10.1021/acs.cgd.7b01206. Epub 2018 Feb 14.

本文引用的文献

2
Pharmaceutical cocrystals and poorly soluble drugs.
Int J Pharm. 2013 Aug 30;453(1):101-25. doi: 10.1016/j.ijpharm.2012.10.043. Epub 2012 Dec 1.
3
pH-dependent solubility of indomethacin-saccharin and carbamazepine-saccharin cocrystals in aqueous media.
Mol Pharm. 2012 Sep 4;9(9):2605-12. doi: 10.1021/mp300189b. Epub 2012 Aug 23.
4
Engineering cocrystal solubility, stability, and pH(max) by micellar solubilization.
J Pharm Sci. 2011 Dec;100(12):5219-34. doi: 10.1002/jps.22725. Epub 2011 Sep 9.
5
Cocrystals of quercetin with improved solubility and oral bioavailability.
Mol Pharm. 2011 Oct 3;8(5):1867-76. doi: 10.1021/mp200209j. Epub 2011 Aug 25.
7
Bioavailability of indomethacin-saccharin cocrystals.
J Pharm Pharmacol. 2010 Nov;62(11):1560-8. doi: 10.1111/j.2042-7158.2010.01189.x.
9
Performance comparison of a co-crystal of carbamazepine with marketed product.
Eur J Pharm Biopharm. 2007 Aug;67(1):112-9. doi: 10.1016/j.ejpb.2006.12.016. Epub 2006 Dec 28.
10
Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.
Pharm Res. 2006 Aug;23(8):1888-97. doi: 10.1007/s11095-006-9032-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验